{"DataElement":{"publicId":"3891069","version":"1","preferredName":"Patient Active Immunotherapy Exclusion Eligibility Determination Yes No Indicator","preferredDefinition":"The yes/no indicator related to a patient's eligibility based on the presence of active immunotherapy.","longName":"Pati_Acti_Immu_Excl_Elig_YES_N","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3891065","version":"1","preferredName":"Patient Active Immunotherapy Exclusion Eligibility Determination","preferredDefinition":"Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures._Exerting influence or producing an effect; taking part in an activity._(IM-yoo-no-THER-a-pee) Treatment to stimulate or restore the ability of the immune system to fight infections and other diseases. Also used to lessen side effects that may be caused by some cancer treatments._Criteria to determine eligibility of patients for medical care programs and services._The deliberate act of omission.","longName":"Pati_Acti_Immu_Excl_Elig","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2183985","version":"1","preferredName":"Patient","preferredDefinition":"Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.","longName":"Patient","context":"CCR","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C0030705","definition":"Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB302B67-DEB0-1206-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-26","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3891773","version":"1","preferredName":"Active Immunotherapy Exclusion Eligibility Determination","preferredDefinition":"Exerting influence or producing an effect; taking part in an activity.:(IM-yoo-no-THER-a-pee) Treatment to stimulate or restore the ability of the immune system to fight infections and other diseases. Also used to lessen side effects that may be caused by some cancer treatments.:The deliberate act of omission.:Criteria to determine eligibility of patients for medical care programs and services.","longName":"C45329:C15262:C82931:C25171","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Active","conceptCode":"C45329","definition":"Exerting influence or producing an effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Immunotherapy","conceptCode":"C15262","definition":"Therapy designed to induce changes in a patient's immune status in order to treat disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Exclusion","conceptCode":"C82931","definition":"The deliberate act of omission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Eligibility Determination","conceptCode":"C25171","definition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E60D14E2-817D-56E4-E040-BB89AD430F6D","latestVersionIndicator":"Yes","beginDate":"2013-09-10","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2013-09-10","modifiedBy":"ONEDATA","dateModified":"2013-09-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E60D14E2-803F-56E4-E040-BB89AD430F6D","latestVersionIndicator":"Yes","beginDate":"2013-09-10","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2013-09-10","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"Pati_Acti_Immu_Excl_Elig_YES_N","type":"USED_BY","context":"CITN"},{"name":"Alliance","type":"USED_BY","context":"Alliance"},{"name":"NRG","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Ipilimumab, anti-PD1, anti-PD","type":"Preferred Question Text","description":"Ipilimumab, anti-PD1, anti-PDL1 or other immunologically active therapy within 12 weeks","url":null,"context":"CTEP"},{"name":"CRF Text 1","type":"Alternate Question Text","description":"Has received prior therapy with an anti-PD-1, anti-PD-L1 and anti-PD-LD2","url":null,"context":"CTEP"},{"name":"CITN","type":"Alternate Question Text","description":"Ipilimumab, anti-PD1, anti-PDL1 or other immunologically active therapy within 8 weeks","url":null,"context":"CITN"},{"name":"CITN text","type":"Alternate Question Text","description":"Ipilimumab, or other immunologically active therapy within 8 weeks of enrollment.","url":null,"context":"CITN"},{"name":"CRF Text 2","type":"Alternate Question Text","description":"Has the patient had prior treatment with anti-PD-1, or anti-PD-L1 therapeutic antibody or pathway-targeting agents?","url":null,"context":"CTEP"},{"name":"CRF Text 3","type":"Alternate Question Text","description":"Has the patient had prior therapy with an anti-PD-1, anti-PD-L1, anti PD-L2, anti-CTLA-4 antibody, or any other antibody or drug specifically targeting T-cell co-stimulation or immune check point pathways?","url":null,"context":"CTEP"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Has patient received prior therapy with an anti-PD-1, anti-PD-L1, or anti PD L2 agent or with an agent directed to another stimulatory or co-inhibitory T-cell receptor?","url":null,"context":"Alliance"},{"name":"NRG_eCRF_Text","type":"Alternate Question Text","description":"Has the patient had prior therapy with CTLA-4 inhibitors or any other antibody or drug specifically targeting T-cell co-stimulation or immune checkpoint pathways?","url":null,"context":"NRG"},{"name":"NRG_CRF_Text","type":"Alternate Question Text","description":"Has the patient had prior therapy with CTLA-4 inhibitors or any other antibody or drug specifically targeting T-cell stimulation or immune checkpoint pathways?","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E60CF88E-99C7-F250-E040-BB89AD436160","latestVersionIndicator":"Yes","beginDate":"2013-09-10","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2013-09-10","modifiedBy":"BOWSERC","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}